J Mitra & Company, a leading Indian in-vitro diagnostics (IVD) manufacturer with a strong global footprint, has been conferred with the ‘Innovative Diagnostic Company of the Year’ award at the National Diagnostics Forum and Awards 2026, organised by Voice of Healthcare. The prestigious ceremony was held in Mumbai and brought together senior leaders, policymakers, clinicians, and innovators from across India’s diagnostics and healthcare ecosystem.
The award recognises J Mitra & Company’s sustained commitment to innovation, indigenous research and development, and its contribution to strengthening diagnostic access and quality across India and international markets. Over the years, the company has built a strong portfolio spanning rapid tests, ELISA, Rapid, and CLIA platforms, addressing critical disease areas, including infectious diseases, chronic conditions, and preventive health screening.
The National Diagnostics Forum is regarded as a key platform for thought leadership and industry recognition, highlighting organisations that are shaping the future of diagnostics through technology, policy engagement, and patient-centric solutions. J Mitra & Company’s recognition underscores its role as a homegrown diagnostics leader that combines scientific rigour with scalable manufacturing and global outreach.
Commenting on the achievement, Jatin Mahajan, Managing Director, J Mitra & Company, said:
“Innovation is not just a function for us; it is the very foundation of our organisation. From investing consistently in R&D to developing technologies that are accurate, affordable, and accessible, innovation guides every decision we take. This recognition by Voice of Healthcare reaffirms our belief that Indian diagnostic companies can lead globally through science-driven solutions. We dedicate this award to our teams, partners, and customers who continuously push us to raise the bar.”
With exports to over 45 countries and a growing focus on advanced technologies such as chemiluminescent immunoassays (CLIA) for point-of-care and laboratory applications, J Mitra & Company continues to align its innovation roadmap with national healthcare priorities and global diagnostic needs.The award further strengthens J Mitra & Company’s position as a trusted diagnostics partner, committed to enabling timely, reliable, and affordable testing, and thereby reinforcing diagnostics as the first line of defence in modern healthcare.
